Recommended Conferences

Genetic Engineering and Gene Therapy

Paris, France

Human Genetics and Genetic Disorders

Miami, USA

Tissue Engineering and Regenerative Medicine

Chicago, USA
Related Subjects
 

Demonstration of novel innate immune cells in psoriasis

Author(s): Mak R, Hundhausen C, Botti E, Laggner U, Grys K, et al.

Abstract

Psoriasis is a common chronic inflammatory skin disorder affecting ~2% of the population worldwide. Both the adaptive and innate immune systems are important in driving the inflammation in genetically susceptible individuals. HLA-Cw6 located within the PSORS1 region on chromosome 6 is the most important psoriasis genetic marker. Correlations of HLA-C expression with different disease incidence and progression are described in the context of HLA-C’s interaction with killer-like immunoglobulin receptors (KIR) expressed on innate immune effector cells; natural killer (NK) and natural killer T (NKT) cells.

Similar Articles

Psoriasis: dysregulation of innate immunity

Author(s): Bos JD, de Rie MA, Teunissen MB, Piskin G

Pathogenesis and therapy of psoriasis

Author(s): Lowes MA, Bowcock AM, Krueger JG

Interleukine-1 and interleukine- 6 in psoriasis

Author(s): Prens EP, Benne K, van DJ, Bakkus M, Brakel K, et al.

The IL-23/ Th 17 Axis in the Immunopathogenesis of Psoriasis

Author(s): Cesare DC, Meglio PD, Nestle FO

Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes

Author(s): Grossman RM, Krueger J, Yourish D, Granelli-Piperno A, Murphy DP, et al.

Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial

Author(s): Chaudhari U, Romano P, Mulcahy L, Dooley L, B aker D, et al.

Histopathologic spectrum of psoriasis

Author(s): Murphy M, Philip K, Grant- Kels JM